Clostridium difficile Infection Perspective

• Donor Factors Shape FMT Success in C difficile Infection The effectiveness of fecal microbiota transplantation in resolving diarrhea associated with C difficile infection is influenced by donor antibiotic use and stool consistency.
  Medscape Medical News, March 20, 2025
• Is Disease Activity in IBD a Risk for C difficile Infection? Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease duration, previous use of corticosteroids, and prior hospitalisation.
  Medscape News UK, February 21, 2025
• Long or Short Antibiotics? Seniors Get Same Results Longer antibiotic courses showed no increased benefits or harms than shorter antibiotic courses in older adults, found a retrospective population-based cohort study.
  Medscape Medical News, February 05, 2025
• Don’t Give Up On FMT for GI Conditions Beyond C difficile   Despite recent setbacks, there is still reason for optimism in regard to FMT as a future treatment option outside of recurrent C difficile infections.
  Medscape Gastroenterology, January 29, 2025
• ACG 2024 8 New GI Studies With Practice-Shifting Implications   Dr David Johnson highlights studies on increasing disease rates, the surprising effects of palliative care consultations, and drugs on the verge of approval.
  Medscape Gastroenterology, November 12, 2024
• Managing Acute Severe UC: Emerging Strategies   Dr Edward Barnes discusses new approaches for improving patient outcomes in acute severe ulcerative colitis.
  Medscape Gastroenterology, October 17, 2024
• Upfront Appendectomy Improves Survival Among Frail Older Adults Immediate surgery is associated with a lower risk for death than nonsurgical treatment or delayed surgery in patients with frailty.
  Medscape Medical News, September 05, 2024
• Diet Conditioning Before FMT Improves Outcomes in UC Patients with UC who received FMT from diet-preconditioned donors, and followed a healthy diet themselves, experienced superior microbial benefits.
  Medscape Medical News, June 14, 2024
• No Benefit to Combo Tx to Prevent Recurrent C diff in IBD Given the high efficacy of fecal microbiota transplantation, adding bezlotoxumab may not provide further reduction in recurrence.
  Medscape Medical News, March 26, 2024
• FMT-Based Therapies for GI Disease: What to Consider   Dr Benjamin Levy highlights key considerations that need to be answered for FMT-based research to make good on its considerable promise.
  Medscape Gastroenterology, March 18, 2024
• The 10 Best GI Studies From 2023 That You Need to Know Dr David Johnson highlights the articles from this year that are most likely to have immediate game-changing implications in your practice.
  Medscape Gastroenterology, December 20, 2023
• Can't-Miss Highlights From ACG 2023: Part 2   Dr David Johnson wraps up his overview on this year's conference with the latest on multitarget stool tests, RSV vaccines in IBD, and other novel findings.
  Medscape Gastroenterology, November 10, 2023
• New and Emerging Options for Treating Recurrent C difficile   Paul G. Auwaerter, MD, discusses treatment options for recurrent C difficile, including new FDA-approved fecal microbiota products.
  Medscape Infectious Diseases, July 28, 2023
• Episode 3: Treating Postinfection and Post-COVID IBS   How do you identify postinfection irritable bowel syndrome? How long will it last and how do you treat it? Join expert physicians Lin Chang and Madhu Grover as they discuss.
  Medscape, May 16, 2023
• Episode 2: Alternative Therapies in UC: An Expert Perspective   Dr Sunanda Kane explores the evidence and effectiveness of alternative therapies with guest, Dr David Hass. From probiotics to CBD to FMT, dive into the various approaches to managing UC.
  Medscape, February 22, 2023
• Bacterial Infections and the Link to PCOS Dr Plotzker discusses intriguing studies examining the link between bacterial infections and PCOS.
  Medscape Diabetes & Endocrinology, December 20, 2022
• S1 Episode 4: The Microbiome and Renal Cell Carcinoma   Drs Sumanta Pal and Jennifer Wargo discuss how the gut microbiome impacts response to cancer therapy in patients with renal cell carcinoma.
  Medscape, November 02, 2022
• 13 Highlights From ACG 2022   Dr David Johnson shares the latest data from this year's meeting, which range from novel treatments for C difficile to the use of virtual reality in treating dyspepsia.
  Medscape Gastroenterology, November 01, 2022
• Caught Up in CAUTIs: The Importance of Diagnostic Stewardship Diagnostic stewardship has proven effective in reducing C diff infections. We need diagnostic stewardship for other hospital acquired infections as well.
  Medscape Infectious Diseases, August 01, 2022
• 8 Must-Read GI Studies for the Primary Care Physician   Gastroenterologist Vivek Kaul, MD, reviews his top picks for primary care clinicians from the 2022 Digestive Disease Week, the premier meeting for the GI specialty.
  Medscape Family Medicine, July 14, 2022